Phase I/IIa Study of FIXFc in Hemophilia B Patients

NCT00716716 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia B

Interventions

DRUG: rFIXFc

Sponsor

Bioverativ Therapeutics Inc.

Collaborators

[object Object]
[object Object]